Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
262.7 USD | +0.62% | +1.74% | +19.43% |
Business Summary
Number of employees: 1,168
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 1,936 | 100.0 % | 2,328 | 100.0 % | +20.20% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
94.6
%
| 1,814 | 93.7 % | 2,202 | 94.6 % | +21.39% |
Rest of World
5.4
%
| 122 | 6.3 % | 125 | 5.4 % | +2.54% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 96-06-25 | |
President | 52 | 11-03-31 | |
James Edgemond
DFI | Director of Finance/CFO | 56 | 12-12-31 |
Dewey Steadman
IRC | Investor Relations Contact | - | - |
Paul Mahon
LAW | General Counsel | 60 | 96-06-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 76 | 01-12-31 |
Chief Executive Officer | 69 | 96-06-25 | |
Tommy Thompson
BRD | Director/Board Member | 81 | 09-12-31 |
Judy Olian
BRD | Director/Board Member | 72 | 15-06-25 |
Katherine Klein
BRD | Director/Board Member | 67 | 14-11-10 |
Louis Sullivan
BRD | Director/Board Member | 90 | 01-12-31 |
Director/Board Member | 60 | 02-10-23 | |
Director/Board Member | 61 | 02-12-31 | |
Richard Giltner
BRD | Director/Board Member | 60 | 09-04-28 |
Nilda Mesa
BRD | Director/Board Member | 64 | 18-10-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 74,250,109 | 43,536,223 ( 58.63 %) | 29,894,415 ( 40.26 %) | 58.63 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CELULARITY INC. 3.66% | 796,885 | 3.66% | 4,167,709 $ |
CLENE INC. 2.23% | 2,869,517 | 2.23% | 1,219,545 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.05% | 11.58B | |
+24.59% | 46.71B | |
+48.83% | 41.8B | |
-1.09% | 41.52B | |
-3.42% | 29.55B | |
+10.40% | 25.78B | |
-20.91% | 19.26B | |
+0.23% | 12.14B | |
-0.36% | 12.08B | |
+25.96% | 11.98B |
- Stock Market
- Equities
- UTHR Stock
- Company United Therapeutics Corporation